메뉴 건너뛰기




Volumn 45, Issue 9, 2006, Pages 1058-1061

Corticosteroids in the management of early and established rheumatoid disease

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; CORTICOSTEROID DERIVATIVE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD COMPLEX; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE; PENICILLAMINE; PLACEBO; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA;

EID: 33749645143     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel230     Document Type: Editorial
Times cited : (9)

References (33)
  • 1
    • 3242677099 scopus 로고    scopus 로고
    • Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial
    • Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
    • (2004) Lancet , vol.364 , pp. 263-269
    • Grigor, C.1    Capell, H.2    Stirling, A.3
  • 2
    • 27744514865 scopus 로고    scopus 로고
    • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study). A randomised controlled trial
    • Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study). A randomised controlled trial. Arthritis Rheum 2005; 52:3381-90.
    • (2005) Arthritis Rheum , vol.52 , pp. 3381-3390
    • Goekoop-Ruiterman, Y.P.M.1    de Vries-Bouwstra, J.K.2    Allaart, C.F.3
  • 3
    • 0034704893 scopus 로고    scopus 로고
    • C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
    • (2000) N Engl J Med , vol.342 , pp. 836-843
    • Ridker, P.M.1    Hennekens, C.H.2    Buring, J.E.3    Rifai, N.4
  • 4
    • 0345072560 scopus 로고    scopus 로고
    • Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset
    • Wallberg-Jonsson S, Johanson H, Ohman ML, Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
    • (1999) J Rheumatol , vol.26 , pp. 2562-2571
    • Wallberg-Jonsson, S.1    Johanson, H.2    Ohman, M.L.3    Rantapaa-Dahlqvist, S.4
  • 5
    • 28544447858 scopus 로고    scopus 로고
    • Disease modification and cardiovascular risk reduction: Two sides of the same coin?
    • Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: Two sides of the same coin? Rheumatology 2005; 44:1473-82.
    • (2005) Rheumatology , vol.44 , pp. 1473-1482
    • Hall, F.C.1    Dalbeth, N.2
  • 6
    • 0141893577 scopus 로고    scopus 로고
    • Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids
    • Morrison E, Crosbie D, Capell HA. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology 2003; 42:1247-50.
    • (2003) Rheumatology , vol.42 , pp. 1247-1250
    • Morrison, E.1    Crosbie, D.2    Capell, H.A.3
  • 7
    • 0029969623 scopus 로고    scopus 로고
    • Corticosteroids in the management of rheumatoid arthritis
    • Morrison E, Capell HA. Corticosteroids in the management of rheumatoid arthritis. Br J Rheumatol 1996;35:2-4.
    • (1996) Br J Rheumatol , vol.35 , pp. 2-4
    • Morrison, E.1    Capell, H.A.2
  • 8
    • 0032725844 scopus 로고    scopus 로고
    • Corticosteroids in rheumatoid arthritis - The case against
    • Morrison E, Capell HA. Corticosteroids in rheumatoid arthritis - the case against. Rheumatology 1999;38:97-100.
    • (1999) Rheumatology , vol.38 , pp. 97-100
    • Morrison, E.1    Capell, H.A.2
  • 9
    • 0029053188 scopus 로고
    • The effect of glucocorticoids on joint destruction in rheumatoid arthritis
    • and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
    • Kirwan J, and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
    • (1995) N Engl J Med , vol.333 , pp. 142-146
    • Kirwan, J.1
  • 10
    • 0030751946 scopus 로고    scopus 로고
    • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    • Boers M, Verhoven AC, Markusse HM et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
    • (1997) Lancet , vol.350 , pp. 309-318
    • Boers, M.1    Verhoven, A.C.2    Markusse, H.M.3
  • 11
    • 0036140321 scopus 로고    scopus 로고
    • Low-dose prednisolone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side-effects: A randomised, double-blind, placebo-controlled clinical trial
    • van Everdingen AA, Jacobs JW, Siewertsz van Reesma DR, Bijlsma JW. Low-dose prednisolone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side-effects: A randomised, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
    • (2002) Ann Intern Med , vol.136 , pp. 1-12
    • van Everdingen, A.A.1    Jacobs, J.W.2    Siewertsz van Reesma, D.R.3    Bijlsma, J.W.4
  • 12
    • 3042739344 scopus 로고    scopus 로고
    • Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: Results of a randomised controlled trial
    • Capell HA, Madhok R, Hunter JA et al. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: Results of a randomised controlled trial. Ann Rheum Dis 2004;63:797-803.
    • (2004) Ann Rheum Dis , vol.63 , pp. 797-803
    • Capell, H.A.1    Madhok, R.2    Hunter, J.A.3
  • 13
    • 27744525171 scopus 로고    scopus 로고
    • Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. A multicenter, double-blind, placebo-controlled trial
    • for the Low-dose Prednisolone Therapy Study Group
    • Wassenberg S, Rau R, Steinfeld P, Zeidler H, for the Low-dose Prednisolone Therapy Study Group. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. A multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:3371-80.
    • (2005) Arthritis Rheum , vol.52 , pp. 3371-3380
    • Wassenberg, S.1    Rau, R.2    Steinfeld, P.3    Zeidler, H.4
  • 14
    • 27744466694 scopus 로고    scopus 로고
    • Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. A two year randomised trial
    • for the BARFOT Study Group
    • Svensson B, Boonen A, Albertsson K, van der Heijde, Kellar C, Hafström I, for the BARFOT Study Group. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. A two year randomised trial. Arthritis Rheum 2005;52:3360-70.
    • (2005) Arthritis Rheum , vol.52 , pp. 3360-3370
    • Svensson, B.1    Boonen, A.2    Albertsson, K.3    van der Heijde4    Kellar, C.5    Hafström, I.6
  • 15
    • 0031696828 scopus 로고    scopus 로고
    • Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis
    • and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
    • Hickling P, Jacoby RK, Kirwan JR. and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 1998;37:930-6.
    • (1998) Br J Rheumatol , vol.37 , pp. 930-936
    • Hickling, P.1    Jacoby, R.K.2    Kirwan, J.R.3
  • 16
    • 0016211783 scopus 로고
    • Minimisation: A new method of assigning patients to treatment and control groups
    • Taves DR. Minimisation: A new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974;15:443-53.
    • (1974) Clin Pharmacol Ther , vol.15 , pp. 443-453
    • Taves, D.R.1
  • 17
    • 0032497095 scopus 로고    scopus 로고
    • Minimisation: The platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does
    • (Editorial)
    • Treasure T, MacRae KD. Minimisation: The platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does (Editorial). Br Med J 1998;317:362-3.
    • (1998) Br Med J , vol.317 , pp. 362-363
    • Treasure, T.1    MacRae, K.D.2
  • 18
    • 84958107344 scopus 로고
    • The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report
    • Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report. Proc Staff Meet Mayo Clin 1949;24:181-97.
    • (1949) Proc Staff Meet Mayo Clin , vol.24 , pp. 181-197
    • Hench, P.S.1    Kendall, E.C.2    Slocumb, C.H.3    Polley, H.F.4
  • 19
    • 70449169625 scopus 로고
    • Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results of three years treatment
    • Empire Rheumatism Council
    • Empire Rheumatism Council. Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results of three years treatment. Ann Rheum Dis 1957;16:277-89.
    • (1957) Ann Rheum Dis , vol.16 , pp. 277-289
  • 20
    • 33144484825 scopus 로고    scopus 로고
    • Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data
    • Da Silva JAP, Jacobs JWG, Kirwan JR et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data. Ann Rheum Dis 2006;65:285-93.
    • (2006) Ann Rheum Dis , vol.65 , pp. 285-293
    • Da Silva, J.A.P.1    Jacobs, J.W.G.2    Kirwan, J.R.3
  • 21
    • 26444573183 scopus 로고    scopus 로고
    • Steroids for Rheumatoid Arthritis: The honeymoon revisited (once again)
    • Caplan L, Russell AS, Wolf F. Steroids for Rheumatoid Arthritis: The honeymoon revisited (once again). J Rheumatol 2005;32:1863-5.
    • (2005) J Rheumatol , vol.32 , pp. 1863-1865
    • Caplan, L.1    Russell, A.S.2    Wolf, F.3
  • 22
    • 27744500020 scopus 로고    scopus 로고
    • Prednisolone in Early Rheumatoid Arthritis: An antiinvasive Effect
    • Harris ED. Prednisolone in Early Rheumatoid Arthritis: An antiinvasive Effect. Arthritis Rheum 2005;52:3324-5.
    • (2005) Arthritis Rheum , vol.52 , pp. 3324-3325
    • Harris, E.D.1
  • 24
    • 0025280914 scopus 로고
    • Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: A 24 week randomised controlled trial
    • Corkill MM, Kirkham BW, Chikanza C, Gibson T, Panayi G. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: A 24 week randomised controlled trial. Br J Rheumatol 1990;29:274-9.
    • (1990) Br J Rheumatol , vol.29 , pp. 274-279
    • Corkill, M.M.1    Kirkham, B.W.2    Chikanza, C.3    Gibson, T.4    Panayi, G.5
  • 25
    • 0025296394 scopus 로고
    • Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis
    • Hansen TM, Kryger P, Elling H et al. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. Br Med J 1990;301:268-70.
    • (1990) Br Med J , vol.301 , pp. 268-270
    • Hansen, T.M.1    Kryger, P.2    Elling, H.3
  • 26
    • 0028997898 scopus 로고
    • Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomised double-blind placebo-controlled trial
    • Van Gestel AM, Laan RFJM, Haagsma CJ, Van de Putte LBA, Van Riel PLCM. Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomised double-blind placebo-controlled trial. Br J Rheumatol 1995;34:347-51.
    • (1995) Br J Rheumatol , vol.34 , pp. 347-351
    • Van Gestel, A.M.1    Laan, R.F.J.M.2    Haagsma, C.J.3    Van de Putte, L.B.A.4    Van Riel, P.L.C.M.5
  • 27
    • 0029967615 scopus 로고    scopus 로고
    • A randomised double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis
    • Ciconelli RM, Ferraz MB, Visioni RA, Oliveira LM, Atra E. A randomised double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1996;35:150-4.
    • (1996) Br J Rheumatol , vol.35 , pp. 150-154
    • Ciconelli, R.M.1    Ferraz, M.B.2    Visioni, R.A.3    Oliveira, L.M.4    Atra, E.5
  • 28
    • 0028273838 scopus 로고
    • Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events
    • Saag KG, Koehke R, Caldwell JR et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. American J Med 1994;96:115-23.
    • (1994) American J Med , vol.96 , pp. 115-123
    • Saag, K.G.1    Koehke, R.2    Caldwell, J.R.3
  • 29
    • 23944483180 scopus 로고    scopus 로고
    • A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs
    • the Intramuscular Methylprednisolone Study Group
    • Choy EH, Kingsley GH, Khoshaba B, Pipitone N, Scott DL, the Intramuscular Methylprednisolone Study Group. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs. Ann Rheum Dis 2005;64:1288-93.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1288-1293
    • Choy, E.H.1    Kingsley, G.H.2    Khoshaba, B.3    Pipitone, N.4    Scott, D.L.5
  • 30
    • 4344578260 scopus 로고    scopus 로고
    • A randomised comparative study of the short term clinical and biological benefits of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
    • Durez P, Nzeusseu Toukap A, Lauwerys BR et al. A randomised comparative study of the short term clinical and biological benefits of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Ann Rheum Dis 2004;63:1069-74.
    • (2004) Ann Rheum Dis , vol.63 , pp. 1069-1074
    • Durez, P.1    Nzeusseu Toukap, A.2    Lauwerys, B.R.3
  • 31
    • 24944573479 scopus 로고    scopus 로고
    • Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: A randomised controlled study
    • Furtado RNV, Olivera LM, Natour J. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: A randomised controlled study. J Rheumatol 2005; 32:1691-8.
    • (2005) J Rheumatol , vol.32 , pp. 1691-1698
    • Furtado, R.N.V.1    Olivera, L.M.2    Natour, J.3
  • 32
    • 26444519878 scopus 로고    scopus 로고
    • Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: What is the true direction of the effect?
    • Davis JM, Maradit-Kremers H, Gabriel SE. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: What is the true direction of the effect? J Rheumatol 2005;32:1856-62.
    • (2005) J Rheumatol , vol.32 , pp. 1856-1862
    • Davis, J.M.1    Maradit-Kremers, H.2    Gabriel, S.E.3
  • 33
    • 0035676529 scopus 로고    scopus 로고
    • High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
    • del Rincón I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
    • (2001) Arthritis Rheum , vol.44 , pp. 2737-2745
    • del Rincón, I.1    Williams, K.2    Stern, M.P.3    Freeman, G.L.4    Escalante, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.